건강한 참가자를 대상으로 한 엘트레키바트(LY3041658) 연구

Inclusion Criteria:

• Are overtly healthy as determined by medical evaluation including medical history and physical examination
• Have a minimum body weight of 45 kilograms (kg).
• Have a body mass index (BMI) within the range of 18.5 to 28.5 kilograms per square meter (kg/m²), inclusive

Exclusion Criteria:

• Have multiple severe allergies to prescription or nonprescription drugs

• Are immunocompromised

• Have had any of the following types of infection within 3 months prior to the screening visit:

  • Serious, that is, requiring hospitalization, or intravenous or equivalent oral antibiotic treatment

  • Opportunistic infections Note: Herpes zoster is considered active and ongoing until all vesicles are dry and crusted over

  • Chronic, that is, duration of symptoms, signs, or treatment of 6 weeks or longer, or

  • Recurring, including, but not limited to:

    • herpes simplex,
    • herpes zoster,
    • recurring cellulitis, or
    • chronic osteomyelitis.

• Are currently pregnant or are intending to become pregnant or to breastfeed at any time in the study or within 16 weeks after receiving the single dose of study intervention.